CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Roche’s Susvimo (ranibizumab injection) 100 mg/mL for the treatment of wet age-related macular degeneration (AMD), bringing the therapy one step closer to authorization across the European Union. The recommendation covers use of Susvimo with the Contivue implant, a refillable ocular implant designed to provide continuous delivery of ranibizumab into the vitreous.

GA in Practice

A panel of experts discusses why they’ve moved toward earlier treatment for geographic atrophy and reviews real-world cases that illustrate the complexity of modern practice.

Geeta A. Lalwani, MD; Murtaza Adam, MD; and Carl J. Danzig, MD, FASRS

Retina Today

Retina specialists have been slowly becoming more comfortable treating patients with geographic atrophy (GA) since the US Food and Drug Administration (FDA) approvals of pegcetacoplan (Syfovre, Apellis/Biogen) and avacincaptad pegol (Izervay, Astellas) in 2023. At first, many of us took a cautious approach to integrating these drugs into our clinical algorithms as we waited to see how real-world patients would react to treatment. In 2026, we are treating patients with a wider variety of clinical presentations and, importantly, we are treating them earlier. To learn more about how and why my colleagues have embraced treatment of early GA, I sat down with Murtaza Adam, MD, and Carl J. Danzig, MD, for a roundtable discussion. We shared real-world cases from our clinics that illustrated the value of early intervention and recorded 3 podcast episodes where we challenged each other on how to treat a series of hypothetical patients whose “real-world” circumstances complicated easy clinical decision-making. Head to Eyetube.net to see our case presentations and listen to New Retina Radio to hear our perspectives. You’ll find ways to directly access the videos and podcasts scattered throughout this discussion. The roundtable below is adapted from our various discussions and has been edited for brevity and clarity. — Geeta Lalwani, MD ▶ Want to watch Drs.

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

Conjunctivochalasis and Hyaluronic Acid in the Dry Eye Space

Eyetube

Co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, sit down with Damon Dierker, OD, FAAO, on To the Point to talk about his approach to conjunctivochalasis. Dr. Dierker notes that he prefers to start the dry eye management process by addressing more common patient symptoms, such as inflammation. If symptoms persist, it’s time to introduce conjunctivochalasis as a diagnosis into the conversation. Dr. Dierker covers what to look for and different treatment options, including a more significant intervention that he has found success with: plasma-based conjunctivoplasty. Drs. Garlich and Quint then pick Dr. Dierker’s brain on hyaluronic acid, how he’s integrated it into his clinic, and patient candidacy.

Eyewire News

07.28.2026

CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending

07.28.2026

BostonSight Reports PROSE Treatment Improved Disease Stage and Visual Acuity in Neurotrophic Keratitis Study

07.28.2026

Claris Biotherapeutics Raises $118 Million to Advance Treatment Candidate for Limbal Stem Cell Deficiency

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

EyewireTV

07.22.2026

The Latest EyewireTV

PRIMA Retinal Implant Launched in Europe Following CE Mark

B+L Launches EyeGility Inserter Preloaded IOL Delivery System in US

Update on Clinical Development Milestone

Stocks

Cataract

A History of TASS Prevention

Twist-and-Out IOL Exchange Followed by Yamane Intrascleral Fixation

MIGS Device Selection in Practice

Rethinking the Drop with iDose TR: Practice Implementation

Cataract Surgery and Hydrus Implantation

Exploring Nd:YAG Vitreolysis After Cataract Surgery for Symptomatic Eyes

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Pediatric Cataract Surgery May Alter Coordination of Ocular Growth, International Study Finds

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

Refractive

Seeing More of the Cornea

The Limits of Combining Phacoemulsification and MIGS

A History of TASS Prevention

Analytics in Ophthalmology

It Is Not Good to Be Shallow

MIGS Device Selection in Practice

07.23.2026

iVeena Reports FDA Alignment on Phase 2 Development Plan for Pediatric Myopia Candidate IVMED-85

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

07.17.2026

iVeena Reports Favorable Phase 1 Safety Data for Investigational Pediatric Myopia Therapy IVMED-85

Stay Updated

Follow Eyewire News

Retina

GA in Practice

ARVO '26: TKIs for Wet AMD and How We Got to the AI Era of Research

Monitoring Pulse During Direct PFCL/SO Exchange

Petaloid Self-Coiling ILM Covering Technique for Macular Hole Repair

Retinal Perfusion, Sensitivity, and Function in DR

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

07.28.2026

CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.24.2026

Topcon Receives CE Mark for GAIA Ultra-Widefield Retinal Imaging System

07.24.2026

Study: Mediterranean Diet Linked to Slower AMD Progression Across Disease Stages

Glaucoma

Canaloplasty and ECP

Visualizing the Angle With Gonioscopy and Swept-Source AS-OCT

Three Weeks of the Wrong Diagnosis—and a Minimally Invasive Path Forward

Three Real-World Scenarios in Which a Minimally Invasive Approach Prevailed

AlloFlo Cleft Creation Troubleshooting: Viscocycloplasty

GATT in a Patient With Steroid-Response Glaucoma and Ocular Surface Medicamentosa

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Glaucoma UK Launches Nationwide Patient Survey Targeting 10,000 Responses